Table 3 Muenchener classification III with correlation to Bethesda classification.
Group | Definition | Correlation to Bethesda classification |
|---|---|---|
0 | Not enough material | Unsatisfactory for evaluation |
I | No abnormality | NILM |
II-a | No abnormality with a history of abnormal cytological diagnosis | NILM |
II-p | Squamous cells with morphological changes but not CIN I | ASC-US |
II-g | Endocervical glands with morphological changes e.g. irritation | AGC endocervical NOS |
II-e | Endometrium glands in women > 40 years old in 2nd phase of cycle | Endometrial cells |
III-p | Atypical squamous cells: CIN II/III or Sq.c.ca are to be considered | ASC-H |
III-g | Atypical glandular cells: AIS/Adenocarcinoma are to be considered | AGC endocervical favor neoplastic |
III-e | Abnormal endometrial glands especially postmenopausal | AGC endometrial |
III-x | Anormal glands not endocervical or endometrial | AGC favor neoplastic |
IIID1 | Squamous cells with mild dysplasia (CIN I) | LSIL |
IIID2 | Squamous cells with moderate dysplasia (CIN II) | HSIL |
IVa-p | Squamous cells with high dysplasia (CIN III) | HSIL |
IVa-g | Endocervical cells with high dysplasia (AIS) | AIS |
IVb-p | Squamous cells with high dysplasia and may be invasion | HSIL with features of invasion |
IVb-g | Endocervical cells with high dysplasia (AIS) and may be invasion | AIS with features of invasion |
V-p | Squamous cell carcinoma | Squamous cell carcinoma (Sq.c.ca) |
V-g | Endocervical adenocarcinoma | Endocervical adenocarcinoma |
V-e | Endometrial adenocarcinoma | Endometrial adenocarcinoma |
V-x | Other type of malignancy | Other malignant neoplasms |
